Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Leases (2019 - 2025)

CorMedix has reported Current Leases over the past 7 years, most recently at $853000.0 for Q4 2025.

  • Quarterly results put Current Leases at $853000.0 for Q4 2025, up 407.74% from a year ago — trailing twelve months through Dec 2025 was $853000.0 (up 407.74% YoY), and the annual figure for FY2025 was $853000.0, up 407.74%.
  • Current Leases reached $853000.0 in Q4 2025 per CRMD's latest filing, up from $579168.0 in the prior quarter.
  • Across five years, Current Leases topped out at $853000.0 in Q4 2025 and bottomed at $112323.0 in Q1 2021.
  • Median Current Leases over the past 5 years was $144532.0 (2023), compared with a mean of $199557.6.
  • The largest annual shift saw Current Leases grew 10.22% in 2022 before it skyrocketed 407.74% in 2025.
  • Over 5 years, Current Leases stood at $121368.0 in 2021, then increased by 11.23% to $135000.0 in 2022, then increased by 11.85% to $151000.0 in 2023, then rose by 11.26% to $168000.0 in 2024, then surged by 407.74% to $853000.0 in 2025.
  • Business Quant data shows Current Leases for CRMD at $853000.0 in Q4 2025, $579168.0 in Q3 2025, and $177172.0 in Q2 2025.